Cargando…

Extra‐cardiac targets in the management of cardiometabolic disease: Device‐based therapies

Heart failure (HF) does not occur in a vacuum and is commonly defined and exacerbated by its co‐morbid conditions. Neurohormonal imbalance and systemic inflammation are some of the key pathomechanisms of HF but also commonly encountered co‐morbidities such as arterial hypertension, diabetes mellitus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jorbenadze, Ana, Fudim, Marat, Mahfoud, Felix, Adamson, Phillip B., Bekfani, Tarek, Wachter, Rolf, Sievert, Horst, Ponikowski, Piotr P., Cleland, John G. F., Anker, Stefan D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	ESC and HFA Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318435/ https://www.ncbi.nlm.nih.gov/pubmed/34002946 http://dx.doi.org/10.1002/ehf2.13361

Ejemplares similares

Heart Failure Association of the European Society of Cardiology position paper on the management of left ventricular assist device‐supported patients for the non‐left ventricular assist device specialist healthcare provider: Part 2: at the emergency department
por: Milicic, Davor, et al.
Publicado: (2021)

HFA of the ESC position paper on the management of LVAD‐supported patients for the non‐LVAD specialist healthcare provider Part 3: at the hospital and discharge
por: Gustafsson, Finn, et al.
Publicado: (2021)

HFA of the ESC Position paper on the management of LVAD supported patients for the non LVAD specialist healthcare provider Part 1: Introduction and at the non‐hospital settings in the community
por: Ben Avraham, Binyamin, et al.
Publicado: (2021)

Protocol update and preliminary results of EACVI/HFA Cardiac Oncology Toxicity (COT) Registry of the European Society of Cardiology
por: Lancellotti, Patrizio, et al.
Publicado: (2017)

Recent advances in cardio‐oncology: a report from the ‘Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019’
por: Anker, Markus S., et al.
Publicado: (2019)

Late phase of COVID‐19 pandemic in General Cardiology. A position paper of the ESC Council for Cardiology Practice
por: Richter, Dimitrios, et al.
Publicado: (2021)

Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF
por: Metra, Marco, et al.
Publicado: (2013)

Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology
por: de Boer, Rudolf A., et al.
Publicado: (2019)

Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)
por: de Boer, Rudolf A., et al.
Publicado: (2022)

Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction—a hospital registry-primary care linked cohort (MINAP–GPRD)
por: Boggon, Rachael, et al.
Publicado: (2011)

Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery disease
por: Goto, Shinya, et al.
Publicado: (2010)

Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial
por: James, Stefan, et al.
Publicado: (2010)

Comparison of cardiac surgery with left atrial surgical ablation vs. cardiac surgery without atrial ablation in patients with coronary and/or valvular heart disease plus atrial fibrillation: final results of the PRAGUE-12 randomized multicentre study(†)
por: Budera, Petr, et al.
Publicado: (2012)

Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT Study
por: Borer, Jeffrey S., et al.
Publicado: (2012)

Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry
por: Steg, Ph Gabriel, et al.
Publicado: (2012)

Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortium(†)
por: Riegger, Julia, et al.
Publicado: (2016)

Universality of sex differences in cardiovascular outcomes: where do we go from here?
por: Miller, Virginia M
Publicado: (2020)

Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists
por: Maas, Angela H E M, et al.
Publicado: (2021)

The 2021 European Heart Failure Guidelines: The Case for Personalised Therapeutics
por: Shanmugam, Nesan
Publicado: (2022)

2021 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronisation Therapy
por: Dan, Gheorghe-Andrei
Publicado: (2021)

New Trial Evidence on Heart Failure: Highlights from the European Society of Cardiology Congress 2021
por: Ferrannini, Giulia, et al.
Publicado: (2022)

European Society of Cardiology Highlights: Late-breaking Science MINOCA/ANOCA
por: Ong, Peter, et al.
Publicado: (2022)

Synchronized diaphragmatic stimulation: a case report of a novel extra‐cardiac intervention for chronic heart failure
por: Goldberg, Lee R., et al.
Publicado: (2022)

Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry
por: Alberts, Mark J., et al.
Publicado: (2009)

MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy): cardiac resynchronization therapy towards early management of heart failure
por: Breithardt, Günter
Publicado: (2009)

DWI Lesion Patterns in Cancer-Related Stroke – Specifying the Phenotype
por: Schwarzbach, Christopher Jan, et al.
Publicado: (2015)

Sex Differences in Long-Term Survival after a First Stroke with Intravenous Thrombolysis: Ebrictus Study
por: Clua-Espuny, José Luis, et al.
Publicado: (2015)

Functional Outcome of Hemorrhagic Transformation after Thrombolysis for Ischemic Stroke: A Prospective Study
por: Annan, Mariam, et al.
Publicado: (2015)

Improving Outcomes Achieved by a New Stroke Program in Hungary
por: Égi, Csilla, et al.
Publicado: (2015)

Subarachnoid Haemorrhage and Sports
por: Sousa Nanji, Liliana, et al.
Publicado: (2015)

The CXCR2 Gene Polymorphism Is Associated with Stroke in Patients with Essential Hypertension
por: Timasheva, Yanina R., et al.
Publicado: (2015)

Periprocedural Risk of Stroke Is Elevated in Patients with End-Stage Renal Disease on Hemodialysis
por: Cherian, Laurel, et al.
Publicado: (2015)

Cancer-Associated Stroke: The Bergen NORSTROKE Study
por: Selvik, Henriette Aurora, et al.
Publicado: (2015)

Highlights of Acute Coronary Syndromes
por: Recio-Mayoral, Alejandro
Publicado: (2022)

The DELIVER Trial: the Beginning of the End of Ejection Fraction Tyranny
por: Bayes-Genis, Antoni
Publicado: (2022)

SECURE, ADVOR and REVIVED: Clinical Trials Presented at ESC 2022
por: Mendieta, Guiomar
Publicado: (2022)

Comment on the ESC Guidelines 2022 for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
por: Cuervo, David Calvo
Publicado: (2023)

ESC Congress 2022 Imaging Highlights
por: Puntmann, Valentina O, et al.
Publicado: (2023)

Pathophysiology and Treatment Opportunities of Iron Deficiency in Heart Failure: Is There a Need for Further Trials?
por: Tkaczyszyn, Michał, et al.
Publicado: (2023)

Synchronized Diaphragmatic Stimulation for Heart Failure With a Reduced Left Ventricular Ejection Fraction Using the VisONE System: A First-in-Patient Study With Extended Population
por: Jorbenadze, Ana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p2cbl3ruie053g1r5u7vpu9bb0